Nelarabine
ATC L01BB07 · 6 markets · 21 records
US 15 records · 1 strengths
- 5 mginjectionArranon__no_trade__
AU 2 records · 2 strengths
- 250 mginjectionNELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial
Records without a stated strength · 1 NELARABINE-REACH
GB 1 records · 1 strengths
- 250 mg/50 mLinjectionAtriance 250mg/50ml solution for infusion vials
CA 1 records · 1 strengths
- 5 mgliquidATRIANCE
ES 1 records · 1 strengths
- 250 mginjectionATRIANCE
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ATRIANCE
| Strength / form / release | US | GB | CA | AU | ES | EU |
|---|---|---|---|---|---|---|
| 250 mg injection | NELARABINE-REACH nelarabine 250 mg/50 mL solution for infusion vial | ATRIANCE | ||||
| 5 mg injection | No trade name Arranon | |||||
| 5 mg liquid | ATRIANCE | |||||
| 250 mg/50 mL injection | Atriance 250mg/50ml solution for infusion vials | |||||
unknown | NELARABINE-REACH | ATRIANCE |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in GB and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en GB que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 GB 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 GB 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.